Keyphrases
Indonesia
100%
COVID-19 Vaccine
45%
CoV-2
37%
People Living with HIV (PLHIV)
32%
Immunogenicity
31%
Autoimmune Disease
25%
Healthy Population
25%
High Risk
23%
Antiretroviral Therapy
20%
COVID-19
19%
Protein Subunit
19%
COVID-19 Infection
17%
SARS-CoV-2 Proteins
15%
Recombinant Vaccine
15%
COVID-19 Vaccination
14%
Integrative Behavior
12%
COVID-19 Vaccination Intention
12%
Knowledge Conditions
12%
Coronavirus Disease 2019 Vaccine
12%
Knowledge-attitude-behavior
12%
Provocation Test
12%
Meta-analysis
12%
Unplanned Interruptions
12%
Socioeconomic Conditions
12%
Hospitalization
12%
Patients with Diabetes Mellitus
12%
Everyday Practices
12%
Nationwide Survey
12%
Tertiary Hospital
12%
Systematic Meta-analysis
12%
Patients with Diabetes
12%
Consensus Guidelines
12%
Healthcare Workers
12%
Influenza Vaccination
12%
COVID-19 Pandemic
12%
First-line Antiretroviral Therapy
12%
Behavioral Model
12%
Allergic Diseases
12%
Immune System
12%
Hereditary Angioedema
12%
Influenza
12%
Virological Outcome
12%
HIV Outcomes
12%
Observational Database
12%
Asia
12%
Long-term Antiretroviral Therapy
12%
Non-alcoholic Fatty Liver Disease (NAFLD)
12%
Immunogenicity Assessment
12%
Phase II Trial
12%
Challenges in Diagnosis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
53%
COVID-19 Vaccine
47%
SARS Coronavirus
33%
Prevalence
28%
Recombinant Vaccine
28%
Autoimmune Disease
25%
HIV
25%
Infection
17%
Pandemic
16%
Adverse Event
15%
Cross-Sectional Study
15%
Neutralizing Antibody
15%
Diseases
14%
Retrospective Study
14%
Systemic Lupus Erythematosus
14%
Provocation Test
12%
Angioneurotic Edema
12%
Coronavirinae
12%
Nonalcoholic Fatty Liver
12%
Cognitive Defect
12%
Allergic Reaction
11%
Vaccine Development
8%
Interleukin 2
8%
Immunosuppressive Agent
5%
Messenger RNA
5%
Placebo
5%
Normal Human
5%
Receptor
5%
Immunology and Microbiology
COVID-19
53%
Immunogenicity
37%
Autoimmune Disease
25%
Seroconversion
16%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Neutralizing Antibody
14%
Systemic Lupus Erythematosus
13%
Synthetic Vaccine
12%
Prevalence
12%
Influenza
12%
T Cell
12%
Protein Subunit
12%
Adoptive Immunity
12%
Vaccine Efficacy
11%
Hypersensitive Response
10%
Interleukin 2
8%
CD4
8%
Titer
6%
Immune System
6%
Normal Human
5%